RESEARCH TRIANGLE PARK – GSK is on the prowl for more acquisitions in 2023, a senior executive tells The Financial Times.
“GSK on hunt for attractive biotechs ‘hiding in plain sight,” The FT reports.
“Chief commercial officer Luke Miels looking at targets worth up to $2.5bn,” the paper adds.
Read the full story at: https://www.ft.com/content/16017258-368d-49eb-8555-4603a63b6726
More from WRAL Techwire
Digital health startup Pattern Health lands $3.3M from investors
Source Node: 1682792
Time Stamp: Sep 23, 2022
Welcome to ‘Walmart Land’ – in a metaverse deal with Roblox
Source Node: 1695026
Time Stamp: Sep 26, 2022
Vaping company Juul Labs, which has operation in Durham, lays off off hundreds
Source Node: 1752986
Time Stamp: Nov 10, 2022
Greene County transit company H&T Trucking to add 70 employees over 5 years
Source Node: 1629024
Time Stamp: Aug 18, 2022
‘Venture Day’ draws a crowd of investors to review a host of promising startups
Source Node: 1760181
Time Stamp: Nov 22, 2022
There’s ‘lot to like’ about Triangle jobs market, economist says – here are 4,000+ open jobs
Source Node: 1747487
Time Stamp: Nov 8, 2022
Private sector hiring slowed in November, below expectations
Source Node: 1764559
Time Stamp: Nov 30, 2022
On the horizon: Previewing 49 statewide events & programs coming up in November
Source Node: 1716664
Time Stamp: Oct 3, 2022
Tesla just can’t make Wall Street happy despite record 1.3M vehicles delivered in ’22
Source Node: 1781880
Time Stamp: Jan 2, 2023
More than a factory: Company coming to Chatham County has track record of building entire communities
Source Node: 1588479
Time Stamp: Jul 22, 2022